`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`NOVARTIS AG AND LTS LOHMANN THERAPIE-SYSTEME AG,
`Patent Owners
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Filed on behalf of:
`Mylan Pharmaceuticals Inc.
`Joseph M. Reisman
`Jay R. Deshmukh
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`Fax: (949) 760-9502
`Ph.: (949) 760-0404
`E-mail: BoxMylan@knobbe.com
`
`By:
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2015-00268
`Patent 6,335,031
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S UPDATED MANDATORY NOTICE INFORMATION
`UNDER 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`
`
`IPR2015-00268
`Mylan v. Novartis
`
`
`Pursuant to 37 C.F.R. § 42.8, Petitioner, Mylan Pharmaceuticals Inc., hereby
`
`submits an updated mandatory notice in connection with the above-captioned Inter
`
`Partes Review of U.S. Patent 6,335,031. This updated mandatory notice is being
`
`timely filed within 21 days of the change of information.
`
`A. Real Party-In-Interest
`
`In accordance with 37 C.F.R. § 42.8(b)(1), Mylan Pharmaceuticals Inc.
`
`hereby gives notice that Mylan N.V. is an additional real party in interest in the
`
`above-captioned Inter Partes Review of U.S. Patent 6,335,031.
`
`B. Related Matters
`
`No change.
`
`C. Lead and Back-Up Counsel
`
`
`
`No change.
`
`D.
`
`Service Information
`
`No change.
`
`1
`
`
`
`
`
`IPR2015-00268
`
`Mylan V. Novartis
`
`Dated: M4155‘!
`
`/7 95/
`
`Respectfully submitted,
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`/%%9f
`
`
`By:
`
`oseph M. Reisman
`Reg. No. 43,878
`Customer No. 20,995
`
`Attorneys for Petitioner
`MYLAN PHARMACEUTICALS INC.
`(949) 760-0404
`
`
`
`IPR2015-00268
`
`Mylan V. Novartis
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that
`
`a true
`
`and correct
`
`copy of
`
`the
`
`foregoing
`
`PETITIONER’S UPDATED MANDATORY NOTICE INFORMATION
`
`UNDER 37 C.F.R. § 42.8(a)(3) is being served on March 19, 2015; Via email
`
`‘ pursuant to 37 C.F.R. § 42.6(e) per agreement of the parties,
`
`to counsel for
`
`Novartis AG and LTS Lohmann Therapie-Systeme AG at the address below:
`
`Exe1onPatchIPR@fchs.com
`
`Raymond R. Mandra
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104
`
`Dated: 4 /? Z61;
`
`
`‘
`
`20236907
`
`oseph M. Reisman, Reg. No. 43,878
`Attorney for Petitioner
`Mylan Pharmaceuticals Inc.